Results of reference pricing and reimbursement discount rate schemes of Turkey

Kockaya, Guvenc; Atikeler, Kagan; Tuna, Esin; Kilic, Pelin; TANYERİ, PELİN; Umman, Nurcan; Vural, Ismail; Altun, Omer; Akbulat, Akif; Artiran, Guven; Simsek, Ercan; Gursoz, Hakki; Kerman, Saim

doi:10.7175/fe.v14i2.473

Results of reference pricing and reimbursement discount rate schemes of Turkey

Atıf İçin Kopyala

Kockaya G., Atikeler K., Tuna E., Kilic P., TANYERİ P., Umman N., ...Daha Fazla

FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, cilt.14, sa.2, ss.99-103, 2013 (ESCI)

Yayın Türü: Makale / Derleme
Cilt numarası: 14 Sayı: 2
Basım Tarihi: 2013
Doi Numarası: 10.7175/fe.v14i2.473
Dergi Adı: FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS
Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI)
Sayfa Sayıları: ss.99-103
Hacettepe Üniversitesi Adresli: Evet

Özet

OBJECTIVES: General Directorate of Pharmaceuticals and Pharmacy (IEGM) is responsible for setting all prices for human medicinal products. The reference pricing system is used for setting these prices. Reference countries are reviewed annually and may be subject to certain alterations. There were 5 reference countries in 2009: Spain, Italy, Germany, France and Greece. The aim of this study is to show the distribution of reference countries which were used for reference pricing.